Patent Laws Affect Drug Innovation
August 27, 2009, Hindustan Times


India’s patent laws are stifling incremental drug innovation, according to a report prepared by the United States India Business Council (USIBC) supported coalition for healthy India, White & Case and Dua Consulting. Ranjit Shahani, President of Organisation of Pharmaceutical Producers of India who is also the Vice Chairman & Managing Director of Novartis, said the industry is in talk with the government for bringing changes in Section 3 (d) of the Indian Patent Act.